Franklin Covey (FC) FY2026 10-K: Record Deferred Revenue, Flat $183M Contract Book
Listen to this report
The Hook
Franklin Covey $FC sold its fiscal 2026 results on a backlog. The November 4 earnings release (Form 8-K) rested its case for growth in fiscal 2027 on deferred revenue: up 4% to $116.1M, and up 17% in Enterprise North America. The 10-K carries the fuller number, and it has not moved. Remaining performance obligations, everything clients have contracted for and the company has not yet recognized, billed or unbilled, were $183.4M at August 31, 2026. A year earlier they were $184.4M. Two years earlier, $183.1M. Deferred revenue grew because more of the same book was invoiced: unbilled contracted revenue fell $5.5M to $67.3M, and refundable customer deposits fell from $16.3M to $8.9M.
That matters more than usual here, because the company spent the year as if the growth were already banked. It bought back 1.5 million shares on the open market for $26.9M, at about $17.90 each, all of it between September 2025 and January 2026, and drew on its revolver in the second quarter to keep buying. Then it stopped. Cash ended the year at $13.3M, down from $31.7M. The stock closed at $13.19 on November 20, 2026 (stockanalysis.com).
Company Snapshot
Franklin Covey Co. (FC), of Salt Lake City, sells leadership and execution training: the All Access Pass subscription and services to companies through its Enterprise Division (North America and International direct offices, plus licensees), and the Leader in Me program to schools through its Education Division. This brief reads the 10-K for the fiscal year ended August 31, 2026, filed November 12, 2026 (accession 0001193125-26-458439), with the two prior 10-Ks and the fiscal 2026 10-Qs for comparison.
The Financial Story
Revenue has fallen two years running, and the contract book has gone sideways. Revenue was $261.5M, down 2% from $267.1M and down 9% from $287.2M in fiscal 2024. North America, the segment the new sales model was built for, fell 3% to $142.6M; International slipped 1% to $40.1M, with the China office down 19%; Education grew 2% to $76.2M. The release's case for fiscal 2027 is that contracted commitments now convert into reported revenue. The filing's own measure of those commitments says the pile is the same size it was in 2024. What changed is its mix.
| August 31 | Remaining performance obligations | Deferred revenue (billed) | Unbilled contracted | Customer deposits |
|---|---|---|---|---|
| 2024 | $183.1M | $107.9M | $75.2M | $17.0M |
| 2025 | $184.4M | $111.7M | $72.8M | $16.3M |
| 2026 | $183.4M | $116.1M | $67.3M | $8.9M |
The billed share of the book rose from 59% to 63% in two years. That is consistent with management's push toward multi-year contracts invoiced up front, and it is real cash discipline. It is not a bigger book. The release's North America figure sharpens the point: Enterprise North America deferred revenue rose $8.8M, to $59.2M from $50.4M, while consolidated deferred revenue rose $4.4M, so deferred revenue in the rest of the company fell about $4.4M. The 10-K does not break performance obligations out by segment, so it cannot say whether North America's own book grew. The deposits line is worth watching on its own: those are prepayments clients make to spend a budget before it lapses, refundable until applied, and the 10-K excludes them from performance obligations. They fell 45%.
Profit improved a little, and the improvement is mostly bookkeeping and cost cuts. Operating income rose to $7.2M from $5.7M on $7.5M less gross profit. Selling, general and administrative expense fell $7.2M, largely restructuring of headcount, and the company spent another $6.7M on restructuring, the same as the year before, with more promised for fiscal 2027. Amortization of acquired intangibles fell $1.9M to $2.5M mainly because the company extended the lives of the Covey Leadership Center content rights by about five years, while amortization of capitalized curriculum, inside cost of revenue, rose to $5.7M from $4.4M. Net income was $4.9M, less than the $6.6M of stock-based compensation it absorbed. Income tax charged was $2.1M, an effective rate of about 30%; the cash that actually went out for income taxes was $1.2M.
Cash is where the year shows. Operating cash flow fell to $21.6M from $29.0M, and to $9.2M of free cash flow after $5.4M of equipment and $7.0M of capitalized curriculum. Deferred revenue and deposits together were a $2.6M drain on operating cash, not a source, because deposits ran off faster than billing grew. Against that $9.2M, the company spent $28.1M on its own shares.
| Fiscal 2026 | Open-market shares | Cost | Average price |
|---|---|---|---|
| Q1 (to Nov 30, 2025) | 582K | $10.4M | $17.87 |
| Q2 (to Feb 28, 2026) | 921K | $16.5M | $17.96 |
| Q3 | 0 | $0 | n/a |
| Q4 | 0 | $0 | n/a |
| Year | 1,503,455 | $26.9M | $17.90 |
Two pre-set trading plans did the buying, $10M from August 2025 and $20M from November 2025, and the second-quarter 10-Q says the company "utilized proceeds from our available line of credit to facilitate purchases of common stock." It drew $11.7M and repaid it before February 28. Over three fiscal years Franklin Covey has bought $67.7M of stock in the open market at an average of $24.02 a share, and $85.3M including shares withheld for employee taxes, against $70.2M of free cash flow. Shareholders' equity fell to $51.4M from $66.9M. The authorization still has $19.7M on it; management told the November 4 call (per the Earnings Whispers transcript) that the near-term priority is to rebuild cash.
Valuation: what it's worth as a normal business
Where it trades. At $13.19 on November 20, 2026 (stockanalysis.com), the 11,335,471 shares on the 10-K cover are worth $149.5M. With $13.3M of cash and nothing drawn on the $62.5M revolver, enterprise value is about $136M: 4.7 times the $28.9M of fiscal 2026 adjusted EBITDA the company reports in its release, 6.1 times that figure after stock compensation, and a 6.2% free cash flow yield on market value. Three analysts cover it, all at Buy, with an average target of $26.06 after cuts on November 5-6 (stockanalysis.com, S&P Global data, read November 21, 2026). Korn Ferry, the closest listed talent and leadership consultancy, trades at 9.0 times EBITDA (stockanalysis.com, November 20, 2026); Skillsoft, the corporate-learning comp, trades as a distressed name and anchors nothing.
Scenario DCF (9% discount rate, 3% terminal growth, five years, plus net cash):
| Case | Starting free cash flow | Growth, years 2-5 | Implied value per share |
|---|---|---|---|
| Bear | $9.2M (fiscal 2026 level) | 0% | $13.38 |
| Base | $13.0M | 4% | $20.94 |
| Bull | $17.0M | 6% | $28.81 |
The base case assumes fiscal 2027 adjusted EBITDA near the $31.5M guidance midpoint converts the way fiscal 2025 did, before the deposit run-off. The bull case needs the guidance top end and a contract book that finally grows. Re-rating: Korn Ferry's 9.0 times applied to Franklin Covey's adjusted EBITDA gives about $24 a share; applied after stock compensation, about $19. What the price implies: at 9% and 3%, on the table's own five-year method, today's $136M enterprise value capitalizes about $9.1M of flat free cash flow, just below the $9.2M of fiscal 2026. The price is the bear case: a business that holds its cash generation and does not grow. This is implied value under stated assumptions, not a price target and not investment advice.
Risks
The contract book is the first risk because the guidance rests on it: if performance obligations stay near $183M, fiscal 2027 revenue growth has to come from faster recognition of the same commitments, which runs out. The 10-K ties results to "the availability of budgeted spending" among clients, which economic conditions can swing, and government clients can end multi-year projects "for lack of approved funding." The company is in a multi-year restructuring with more charges promised. China moves to a licensee by the end of the second quarter of fiscal 2027 (Note 3); the release puts the revenue cost at about $2.0M. The thin cash cushion now depends on a revolver that matures March 27, 2028 and restricts buybacks to compliance with leverage and fixed-charge covenants. One new disclosure: the related-party note now reports payments to a video production company owned by the brother of a member of executive management, $1.4M in fiscal 2026 against $0.4M a year earlier, a paragraph the fiscal 2025 10-K did not carry. On the insider side, the Chief Product Officer sold 8,000 shares at $15.425 on November 10, 2026 (Form 4), below the $17.90 the company paid for its own.
The Bottom Line
Franklin Covey is a cash-generative training company whose price implies no growth, and its own filings give a reason: the record deferred revenue is a billing shift inside a contract book that has held at $183-184M for three years, and the cash that would have cushioned a slow fiscal 2027 went into $26.9M of stock bought near $17.90. What to watch: performance obligations in the first two fiscal 2027 10-Qs (growth above $184M is the first evidence the sales model adds business rather than accelerating it), whether customer deposits stabilize, and whether buybacks resume before cash rebuilds. Nobody wrote this by hand from a press release. Every Franklin Covey number here came out of its SEC filings (the 10-Ks, the fiscal 2026 10-Qs and the November 4 earnings release on Form 8-K), read by machine, and the same reading works on any filer whose headline metric and filed obligations tell different stories.
Figures from Franklin Covey's SEC filings (10-K for fiscal 2026, 2025 and 2024; 10-Qs for fiscal 2026; 8-K of November 4, 2026), read through RoboSystems. Market data as attributed.
Ask the filing yourself
Every figure in this report came from Franklin Covey Co.'s SEC filings in the RoboSystems SEC Shared Repository. Connect it to Claude or ChatGPT and ask your own questions, starting with this one:
What were Franklin Covey's remaining performance obligations and deferred revenue at August 31 in 2024, 2025 and 2026?